Jim Simons Galmed Pharmaceuticals Ltd. Transaction History

Renaissance Technologies LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.35 - $0.65 $6,716 - $12,472	19,189 Added 60.72%	50,789 $16,000
Q2 2022 Aug 12, 2022	BUY	$0.44 - $1.77 $13,904 - $55,932	31,600 New	31,600 $21,000
Q2 2021 Aug 13, 2021	SELL	$2.24 - $3.9 $135,968 - $236,730	-60,700 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$3.19 - $5.4 $175,769 - $297,540	-55,100 Reduced 47.58%	60,700 $208,000
Q4 2020 Feb 10, 2021	BUY	$3.06 - $4.17 $249,567 - $340,096	81,558 Added 238.18%	115,800 $360,000

Q3 2020 Nov 13, 2020	SELL	$3.46 - $5.69 $151,416 - $249,005	-43,762 Reduced 56.1%	34,242 $121,000
Q2 2020 Aug 13, 2020	BUY	$3.22 - $6.08 $122,050 - $230,456	37,904 Added 94.52%	78,004 $373,000
Q1 2020 May 14, 2020	SELL	$3.3 - $6.84 $81,866 - $169,686	-24,808 Reduced 38.22%	40,100 $139,000
Q4 2019 Feb 13, 2020	BUY	$3.61 - $6.75 $174,756 - $326,760	48,409 Added 293.41%	64,908 $375,000
Q3 2019 Nov 13, 2019	SELL	$4.62 - $7.11 $73,000 - $112,345	-15,801 Reduced 48.92%	16,499 $79,000
Q2 2019 Aug 12, 2019	SELL	$5.68 - $8.68 $2,840 - $4,340	-500 Reduced 1.52%	32,300 $237,000
Q1 2019 May 14, 2019	SELL	$7.27 - $9.07 $5,816 - $7,256	-800 Reduced 2.38%	32,800 $268,000
Q4 2018 Feb 13, 2019	BUY	$6.59 - $14.47 $221,424 - $486,192	33,600 New	33,600 $229,000

Ticker GLMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,088,400
Market Cap $7.78M
Description
Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, an oral therapy, which is in Phase III study for the treatment of non-alcoholic steato-hepatitis (NASH) in patients with overweight or obesity and who are pre-diabetic or t...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.